In vitro 3D colon tumor penetrability of SRJ09, a new anti-cancer andrographolide analog
Limited tumor penetrability of anti-cancer drugs is recognized as one of the major factors that lead to poor anti-tumor activity. SRJ09 (3,19-(2-bromobenzylidene) andrographolide) has been identified as a lead anti-cancer agent for colon cancer. Recently, this compound was shown by us to be a mutant...
|Main Authors:||, , , , , , , ,|